Dr. Doebele and his CU Cancer Center research team drive development of targeted-therapy drug that shows great promise
Chris Casey - University Communications
Tears stream from behind Nichol Miller’s glasses as she studies the latest CAT scan of her torso. Where just four months ago tumors covered both lungs, now only a few tiny dots appear.
The CAT scan at left was taken March 2, 2015, at the CU Cancer Center when patient Nichol Miller’s lungs were covered with tumors. At right is her most recent CAT scan, showing the success of the targeted-therapy drug she is taking as part of a clinical trial.